Inhibition of macrophage activation and phagocytosis by a novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin
- 30 November 2006
- journal article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 60 (9), 578-586
- https://doi.org/10.1016/j.biopha.2006.07.089
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prevention of Cancer Cachexia by a Novel Nuclear Factor κB Inhibitor in Prostate CancerClinical Cancer Research, 2005
- Toll-like Receptor SignalingJournal of Biological Chemistry, 2003
- Inflammation and cancerNature, 2002
- Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by DehydroxymethylepoxyquinomicinPublished by Elsevier BV ,2002
- Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappa BAnnals Of The Rheumatic Diseases, 2000
- Synthesis of NF-κB activation inhibitors derived from epoxyquinomicin CBioorganic & Medicinal Chemistry Letters, 2000
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Secretory products of macrophages.JCI Insight, 1987